Search Tag: hydroxychloroquine

Executive Health Management

FDA & MHRA Revoke COVID-19 Authorisations for Hydroxychloroquine

2020 16 Jun

The U.S. Food and Drug Administration has revoked its emergency use authorisation for chloroquine and hydroxychloroquine as treatments for COVID-19. The U.K. Medicines and Healthcare products Regulatory Agency has followed suit, but Brazil criticised the decision and expanded the drugs’ use.   You might also like: Warnings about Potential... Read more

Executive Health Management

Potential COVID-19 Treatments: Some In, Some Out

2020 27 May

The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold.   You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration... Read more

ICU Management

Volume 20 - Issue 1, 2020

2020 19 May

Change content default value Read more

ICU Management

From Hydroxychloroquine and Remdesivir to Plasma Administration

2020 19 May

Clinicians are faced with a serious disease with no effective therapy. Several options are being considered to treat COVID-19, but how promising are these drugs? A  number of colleagues and friends from outside the hospital have asked me whether they should take hydroxychloroquine for their COVID-19. A friend asked me whether he should... Read more

ICU Management

Association Between Hydroxychloroquine or Azithromycin and In-Hospital Mortality

2020 18 May

As of May 2020, at least a quarter of a million people worldwide have died from COVID-19. Over the past four months, many treatments have been suggested for this disease but none have worked so far. Hydroxychloroquine has been too much in the news, in particular.  Laboratory evidence has indicated that the use of hydroxychloroquine can inhibit the... Read more

Cardiology Management

Hydroxychloroquine and QT Prolongation

2020 06 May

As the healthcare community attempts to deal with the coronavirus disease (COVID-19), there is an intense effort to develop an effective treatment strategy. While research on the development of a vaccine continues, clinicians have been forced to use treatments that lack robust clinical evidence. With many patients succumbing to acute respiratory distress... Read more

Executive Health Management

Warnings about Potential Treatments for COVID-19

2020 09 Apr

An early-released review warns about potentially serious adverse events for chloroquine, hydroxychloroquine and azithromycin when used to treat and prevent COVID-19 . It comes only days after the U.S. Centers for Disease Control and Prevention (CDC) had removed guidelines for using hydroxychloroquine as a potential treatment.  ... Read more

Executive Health Management

COVID-19: No Approval for Chloroquine from EMA

2020 03 Apr

The European Medicines Agency has warned against widespread use of the drug chloroquine to treat COVID-19 .   You may also like: COVID-19: From Hydroxychloroquine to Plasma Administration   An unproven medicine against COVID-19, chloroquine and the less toxic hydroxychloroquine are currently licensed to treat malaria... Read more